NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research ...

Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core structure of many biologically active compounds. Derivatives of indole, ...

Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and ...

BUFFALO, N.Y. – The Empire Discovery Institute has entered into a collaborative research partnership with the National Multiple Sclerosis Society and its commercial development program Fast Forward, ...

Queen Mary researchers led by Dr. Emanuel Rognoni and Dr. Matthew Caley, with backing from DEBRA Research, have begun a new ...

Merck (NYSE:MRK) has canceled plans for a £1B research center in London and will lay off over 100 scientists, the Financial ...

Three scientists who helped in developing the cystic fibrosis drug that extends life by decades have won the prestigious ...